---
schema_version: "secwatch.filing_event.v1"
accession: "0000719135-23-000022"
form_type: "8-K"
ticker: "APYX"
cik: "0000719135"
company_name: "Apyx Medical Corp"
filed_at: "2023-04-18T23:59:59+00:00"
generated_at: "2026-06-17T00:59:54.084866+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Apyx Medical extends property sale inspection period to May 4, 2023, closing to May 8

## Summary
- Amendment extends Inspection Period for Clearwater facility sale to 5:00 p.m. ET on May 4, 2023.
- Closing deadline extended to on or before May 8, 2023; purchase price remains $7.65 million.
- All other terms of the original Purchase and Sale Agreement unchanged.
- Original agreement signed March 14, 2023; buyer VK Acquisitions VI, LLC.

## SEC filing metadata
- accession: 0000719135-23-000022
- form_type: 8-K
- ticker: APYX
- cik: 0000719135
- company_name: Apyx Medical Corp
- filed_at: 2023-04-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/719135/000071913523000022/0000719135-23-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/719135/000071913523000022/apyx-20230413.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000719135-23-000022
- JSON: https://secwatch.observer/filing/0000719135-23-000022.json
- Plain text: https://secwatch.observer/filing/0000719135-23-000022.txt

## Key facts
- Material Agreements
  Apyx Medical Corp amended First Amendment to Purchase and Sale Agreement with VK Acquisitions VI, LLC (effective 2023-04-13).
  - Action: amendment
  - Agreement: asset purchase
  - Counterparty: VK Acquisitions VI, LLC
  - Effective: 2023-04-13
  source text: First Amendment to Purchase and Sale Agreement, dated April 12, 2023 : As previously reported by Apyx Medical Corporation (the “Company”) in a Current Report on Form 8-K filed with the Securities and Exchange Commission on March 15, 2023, on March 14, 2023 the Company entered into a Purchase and Sale Agreement (the “Purchase Agreement”) with VK Acquisitions VI, LLC (the “Purchaser”), for the sale of the Company’s facility located at 5115 Ulmerton Road, Clearwater, Florida, as more fully described in the Purchase Agreement (collectively, the “Property”) for a purchase price of $7,650,000. Pursuant to the terms of the Purchase Agreement, the Purchaser initially had thirty (30) days from the date of execution to complete its satisfactory due diligence of the Property (the “Inspection Period”), during which time the Purchaser retained the right to cancel the Purchase Agreement. The initial closing of the transaction was to be held five (5) days following the expiration of the Inspection Pe
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000071913523000022/0000719135-23-000022-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.